Alyeska Investment Group
EXAS

Alyeska Investment Group’s Exact Sciences EXAS Stock Holding History

Alyeska Investment Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,027
Closed -$206K – 590
2024
Q3 		$206K Buy
+3,027
New +$171K ﹤0.01% 505
2024
Q2 		– Sell
-150,000
Closed -$10.4M – 598
2024
Q1 		$10.4M Sell
150,000
-175,000
-54% -$11.1M 0.06% 273
2023
Q4 		$24M Sell
325,000
-736,052
-69% -$48.2M 0.16% 180
2023
Q3 		$72.4M Buy
1,061,052
+710,428
+203% +$60.3M 0.49% 61
2023
Q2 		$32.9M Buy
+350,624
New +$27.4M 0.24% 137
2022
Q1 		– Sell
-75,000
Closed -$5.84M – 601
2021
Q4 		$5.84M Buy
+75,000
New +$6.62M 0.07% 261
2020
Q4 		– Sell
-54,858
Closed -$5.59M – 538
2020
Q3 		$5.59M Buy
+54,858
New +$4.74M 0.09% 246
2019
Q1 		– Sell
-191,389
Closed -$12.1M – 404
2018
Q4 		$12.1M Sell
191,389
-28,738
-13% -$1.97M 0.18% 152
2018
Q3 		$17.4M Buy
+220,127
New +$14.4M 0.19% 138
2017
Q3 		– Sell
-450,447
Closed -$15.9M – 485
2017
Q2 		$15.9M Sell
450,447
-327,301
-42% -$10.1M 0.13% 202
2017
Q1 		$18.4M Buy
+777,748
New +$15.4M 0.15% 199
2016
Q1 		– Sell
-97,569
Closed -$901K – 407
2015
Q4 		$901K Buy
97,569
+32,861
+51% +$306K 0.01% 343
2015
Q3 		$1.16M Buy
64,708
+49,098
+315% +$1.13M 0.01% 379
2015
Q2 		$464K Sell
15,610
-13,560
-46% -$341K 0.01% 455
2015
Q1 		$642K Buy
+29,170
New +$740K 0.01% 459
2013
Q4 		– Sell
-213,912
Closed -$2.52M – 330
2013
Q3 		$2.52M Sell
213,912
-200,000
-48% -$2.57M 0.1% 205
2013
Q2 		$5.76M Buy
+413,912
New +$4.5M 0.28% 115

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alyeska Investment Group's EXAS Position: Q4 2024 in Review

Alyeska Investment Group sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 3,027 shares — an estimated $206K sold.

Alyeska Investment Group first reported a position in EXAS in Q2 2013 and held it in 17 quarters. The position peaked at $72.4M in Q3 2023. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Alyeska Investment Group reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 3,027 Exact Sciences shares in Q4 2024, an estimated $206K.
  • Alyeska Investment Group first reported a position in Exact Sciences in Q2 2013 and held it in 17 quarters.
  • Alyeska Investment Group's Exact Sciences position peaked at $72.4M in Q3 2023.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Alyeska Investment Group's 13F filing for Q4 2024, filed 14 Feb 2025.